Dr. Buckley’s presentation, entitled: “Application of Liquid Biopsy to the Detection and Treatment of Ovarian Cancer” will focus on a project that she is currently working on.
About Dr. Buckley
Dr Niamh Buckley graduated from Trinity College, Dublin in 2002 with a First Class Honours Degree in Biochemistry. She then carried out her Ph.D training in the Department of Oncology (Queen’s University Belfast) under the supervision of Prof. Paul Harkin. Following this, she then worked as a post-doctoral researcher with Dr Paul Mullan in the Centre for Cancer Research and Cell Biology (Queen’s University Belfast). During this time she investigated the role of the breast and ovarian tumour suppressor gene, BRCA1, in stem cell regulation and mammary gland differentiation.
Dr Buckley was awarded the prestigious Breast Cancer Now Fellowship in 2013 to develop novel biomarkers and therapeutic strategies in BRCA1-mutant and/or triple negative breast cancer. In 2016 she was appointed as a Lecturer in Personalised Medicine and Pharmacogenomics in the School of Pharmacy (Queen’s University Belfast). Her research focuses on the integration of in vitro, in vivo, bioinformatics and pathology approaches to identify key pathways underpinning poor outcome breast cancer and use detailed knowledge of this biology to identify appropriate targeted treatment options, personalising therapy in an area of unmet clinical need.
About Pathology Horizons
Pathology Horizons is an annual CPD conference focused on the future of pathology. Delegates will learn about new technologies, procedures and lines of research that are driving the future of pathology. This year the conference is being held in the five star Lough Erne Resort, Co. Fermanagh in N.Ireland from 13-15 September 2018.